Notably, previous studies have shown that systemic administration of LPS-injection significantly elevated the protein expression levels of p-JNK level, AD markers (APP, BACE-1, Aβ, and p-Tau) that ultimately developed into axonal pathology and dendritic degeneration in rodent brains [14]. This evidence concerns the gene APP and Alzheimer disease.